NCT03037515View on ClinicalTrials.gov

Oral and Intravenous Tranexamic Acid in Lumbar Spine Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

February 15, 2017

Primary Completion Date

June 15, 2018

Study Completion Date

July 16, 2018

Conditions
Blood Loss, SurgicalBlood Loss Anemia
Interventions
DRUG

Tranexamic Acid

To identify if intravenous tranexamic acid is superior to oral tranexamic acid in reducing blood loss and need for transfusion in lumbar spine surgery.

Trial Locations (1)

48202

Henry Ford Health System, Detroit

All Listed Sponsors
lead

Henry Ford Health System

OTHER

NCT03037515 - Oral and Intravenous Tranexamic Acid in Lumbar Spine Surgery | Biotech Hunter | Biotech Hunter